Turner White CommunicationsAbout TWCSubscribeContact TWCHomeSearch
Hospital PhysicianJCOMSMPBRMsCart
Current Contents
Past Issue Archives
Interactive:
Self-Assessment Questions
Review of
Clinical Signs
Clinical Review
Quiz
Pediatric Rounds
Resident Grand Rounds
Article Archives
Case Reports
Clinical Practice
Exams
Pediatric Rounds
Resident Grand Rounds
Review of
Clinical Signs

Guide to Reading
Hospital Physician
Editorial Board
Information for Authors

Reprints, Permissions, & Copyright
Site Map
Self-Assessment Questions

Pediatric Medicine


Answer 1
  1. Administer naloxone 0.1 mg/kg body weight intravenously with close cardiovascular monitoring. This child ingested his grandfather’s blood pressure medicine. Clonidine is an antihypertensive agent that exerts its effect through stimulation of alpha2-adrenergic receptors. It is an extremely potent drug, with typical doses of 0.1 to 0.2 mg in adults. Therefore, ingestion of small amounts can potentially lead to significant toxicity in children. Clonidine has excellent central nervous system (CNS) penetration because of high lipid solubility. Clinical features suggestive of clonidine ingestion include lethargy, apnea, bradycardia, profound hypotension, and miosis. The treatment requires immediate assessment and management of the patients airway, breathing, and circulation. Gastrointestinal (GI) decontamination may be ineffective 2 hours after ingestion, because clonidine is rapidly absorbed from the GI tract. Therapy or maneuvers that cause emesis also should be avoided in this child, because they can cause aspiration. Even placement of a nasogastric tube should not be performed in a comatose child before intubating the child. Naloxone has been suggested as a specific antidote for clonidine overdose and often may improve mental status and cardiorespiratory function.

Click here to return to the questions

 

Hospital Physician     JCOM     Seminars in Medical Practice
Hospital Physician Board Review Manuals
About TWC    Subscribe    Contact TWC    Home    Search   Site Map

Copyright © 2009, Turner White Communications
Updated 1/04/08 • kkj